The present invention relates to compounds of Formula VIII with absolute configuration R or S:
as well as pharmaceutically acceptable salts, hydrates, or solvates thereof, wherein the variables are described herein. The present invention further relates to pharmaceutical compositions which comprise the compounds of Formula VIII, and to methods for inhibiting protein kinase and methods of treating diseases, such as cancers, inflammation.
本发明涉及具有绝对构型R或S的VIII式化合物,以及其药学上可接受的盐、
水合物或溶剂化物,其中变量在此描述。本发明还涉及包括VIII式化合物的制药组合物,以及抑制蛋白激酶的方法和治疗疾病的方法,例如癌症、炎症等。